Clinical Trials
5 trialsNCT07124858 2026-05-26
COFRUQ
Federation Francophone de Cancerologie Digestive
Phase NA Recruiting
NCT07235293 2026-05-22
A Study to Test DSP107 in Combination With Atezolizumab in Comparison With Fruquintinib as a New Treatment for Colorectal Cancer.
Kahr Medical
Phase 2 Recruiting
NCT06562543 2026-05-20
A Trial to Evaluate the Safety and Activity of Fruquintinib in Minority Populations With Advanced, Previously Treated Colorectal Cancer
Takeda
Phase 4 Recruiting
NCT07591597 2026-05-18
IGNITE-CRC
National Cancer Center Hospital East
Phase 1/2 Not yet recruiting
NCT07136077 2026-05-15
A Phase 2 Trial of Fruquintinib and Tislelizumab in ctDNA-defined Minimal Residual Disease in Colorectal Cancer After Completion of Adjuvant Chemotherapy
M.D. Anderson Cancer Center
Phase 2 Recruiting